Luz Graciela Cervantes-Pérez

Author

Also Known As

L.G. Cervantes-Pérez, Luz G. Cervantes-Pérez, Luz Cervantes‐Perez, Luz G Cervantes-Pérez, Luz G. Cervantes-Perez, Luz G. Cervantes-Pérez, Luz Graciela Cervantes-Perez, Luz Graciela Cervantes-Pérez, Luz Graciela Cervantes‐Perez

Publications

677

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional de Cardiología Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Instituto Politécnico Nacional Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Universidad Nacional Autónoma de México

About

Luz Graciela Cervantes-Pérez is an author at Instituto Nacional de Cardiología specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	270
2	Biochemistry	2	2	168
3	Endocrinology	2	2	132
4	Public Health	1	1	107
5	Cellular Physiology	1	1	107

Luz Graciela Cervantes-Pérez

Publications

634

Citations

H-Index

Page 1

	Year	Citations
Activation of the renal Na <sup>+</sup> :Cl <sup>−</sup> cotransporter by angiotensin II is a WNK4-dependent process María Castañeda‐Bueno, Luz Graciela Cervantes-Pérez, Norma Vázquez, Proceedings of the National Academy of Sciences	2012	256
Modulation of NCC activity by low and high K<sup>+</sup> intake: insights into the signaling pathways involved María Castañeda‐Bueno, Luz Graciela Cervantes-Pérez, Lorena Rojas‐Vega, American Journal of Physiology-Renal Physiology NutritionSignaling PathwaysAng IiCellular PhysiologyOxidative Stress	2014	107
Clofibrate PPARα Activation Reduces Oxidative Stress and Improves Ultrastructure and Ventricular Hemodynamics in No-flow Myocardial Ischemia Luz Ibarra-Lara, Enrique Hong, Elizabeth Soria‐Castro, Journal of Cardiovascular Pharmacology Lipid PeroxidationCardiovascular PharmacologyCardiovascular FunctionRedox BiologyOxidative Stress	2012	61
The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway Silvana Bazúa‐Valenti, Lorena Rojas‐Vega, María Castañeda‐Bueno, Journal of the American Society of Nephrology	2018	43
Peroxisome proliferator-activated receptors (PPAR) downregulate the expression of pro-inflammatory molecules in an experimental model of myocardial infarction Luz Ibarra-Lara, María Sánchez-Aguilar, Elizabeth Soria‐Castro, Canadian Journal of Physiology and Pharmacology Heart FailurePro-inflammatory MoleculesImmune RegulationImmunologyPpar Stimulation	2016	29
PPARα stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner Luz Ibarra-Lara, Luz Graciela Cervantes-Pérez, Francisca Pérez‐Severiano, European Journal of Pharmacology Molecular PharmacologyHypertensionMolecular PhysiologyPparα StimulationMedicine	2009	25
Hyperglycemic levels in early stage of diabetic nephropathy affect differentially renal expression of claudins-2 and -5 by oxidative stress Lorena Rosas-Martínez, Rafael Rodríguez‐Muñoz, María del Carmen Namorado-Tonix, Life Sciences	2021	24
Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle Luz Ibarra-Lara, Leonardo del Valle‐Mondragón, Elizabeth Soria‐Castro, Pharmacological Reports Vasodilator EnvironmentHeart FailureMolecular PhysiologyCardiovascular DiseaseMedicine	2016	20
Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects Fabiola Cortes-Lopez, Alicia Sánchez-Mendoza, David Centurión, PPAR Research	2021	17
Clofibrate Treatment Decreases Inflammation and Reverses Myocardial Infarction-Induced Remodelation in a Rodent Experimental Model Luz Ibarra-Lara, María Sánchez-Aguilar, Elizabeth Soria‐Castro, Molecules Heart FailureImmunologyImmune RegulationCell DeathPharmacotherapy	2019	16

Page 1